世界の小児用臨床試験市場2022-2030:フェーズ別(フェーズII、IV)、研究デザイン別(治療、観察研究)、治療領域別(精神疾患、がん)

【英語タイトル】Pediatric Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase II, IV), By Study Design (Treatment, Observational Studies), By Therapeutic Areas (Mental Health Disorders, Oncology), And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GRV22JL082)・商品コード:GRV22JL082
・発行会社(調査会社):Grand View Research
・発行日:2022年5月16日
・ページ数:275
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

グランドビューリサーチ社は、世界の小児用臨床試験市場規模が2022年から2028年の間に年平均5.1%成長し、2030年までに236億ドルに達すると予測しています。本調査レポートでは、小児用臨床試験の世界市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、フェーズ別(フェーズII、IV)分析、研究デザイン別(治療研究、観察研究)分析、治療領域別(精神疾患、がん、自己免疫・炎症性疾患、呼吸器疾患、その他)分析、地域別分析、企業情報などを掲載しています。本調査レポートでは、ICON plc、Syneos Health、Medpace, Inc.、PPD Inc.、Premier Research、LabCorp Drug Development、QPS Holdings.、Pfizer Inc.、The Emmes Company, LLC、IQVIA Inc.などの企業情報が含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界の小児用臨床試験市場規模:フェーズ別(フェーズII、IV)
・世界の小児用臨床試験市場規模:研究デザイン別(治療研究、観察研究)
・世界の小児用臨床試験市場規模:治療領域別(精神疾患、がん、自己免疫・炎症性疾患、呼吸器疾患、その他)
・世界の小児用臨床試験市場規模:地域別
・企業情報

小児用臨床試験市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の小児用臨床試験市場規模は2030年までに236億米ドルに達する見込みで、予測期間中の年平均成長率は5.1%です。同市場は、世界的な小児用臨床試験数の増加により成長しています。BMCジャーナルによると、2008年1月から2010年12月の間に7,029件の小児用臨床試験が登録されました。一方、2017年1月から2019年12月の間に、登録された小児用臨床試験の数は11,738件であり、これは確かに業界全体の試験総数の大幅な急増を反映しています。COVID-19小児患者に対する治療選択肢はパンデミック開始時には限られていましたが、そのため2020年5月、FDAは成人および小児のCOVID-19治療に使用可能なVeklury(remdesivir)の緊急使用承認(EUA)を付与しました。

同様に、Convalescent plasmaも小児および成人のCOVID-19の治療薬としてFDAからEUAを取得しました。このような規制当局の動きは、小児用臨床試験の需要を促進すると思われます。さらに、小児疾患に関連する臨床研究を支援するための複数の政府機関による取り組みが増加していることも、市場の成長をさらに後押ししています。例えば、2022年3月、米国国立がん研究所は、小児腫瘍の分子特性化イニシアチブを立ち上げました。このイニシアチブはNCIのChildhood Cancer Data Initiativeを通じて提供されるもので、小児腫瘍学を研究する研究者間でのデータ共有と新しいデータの収集を促進するために設立されました。

さらに、小児がんの有病率の増加も、腫瘍学分野と同様に市場の成長を支える重要な要因です。例えば、米国臨床腫瘍学会(ASCO)が2022年2月に述べたように、米国では2022年末までに推定10,470人の15歳未満の小児と約5,480人の15歳から19歳の10代の若者ががんと診断されます。WHOは、下痢、マラリア、肺炎、敗血症が生後1カ月から9歳までの子どもの主な死因であるとしています。したがって、市場の成長にプラスの影響を与える可能性が高いです。感染症による高い負担とは別に、かなりの数の子供たちが糖尿病に苦しんでいます。

例えば、米国CDCによると、米国では2018年に2,690万人以上が糖尿病と診断され、この中には21万人の20~25歳未満の小児および青年が含まれています。商業的には、COVID19ワクチンは18歳以上の成人への接種が中心であったため、18歳未満の小児に高い罹患リスクがありました。ClinicalTrial.GOVによると、2022年5月4日現在、小児患者を対象としたCOVID-19の治療・診断のための研究が1000件以上行われています。小児におけるCOVID-19の負担は、2021年以降、小児科向けのCOVID-19ワクチン試験の需要を促進すると考えられます。

小児用臨床試験市場レポートハイライト

- 観察研究セグメントは予測期間中にかなりの成長率を記録する見込みです。これらの試験は、治療によるまれな転帰を調査し、異常な副作用を検出するために行われます。このような要因が、小児科における観察研究の需要を促進しています。

- フェーズIIセグメントは2021年に最大のシェアを占めました。第II相試験は、多くの小児科被験者で構成され、さらに、この相の試験は他の相の試験よりも複雑です。このような要因が、同セグメントが高いシェアを占める要因となっています。

- 治療分野別では、小児がんの負担が大きいことから、2021年にはがん分野がその他分野に次いで最大のシェアを占め、臨床試験の需要に貢献しました。

- アジア太平洋地域は人口が多く、新たな治療法の需要に貢献していることから、予測期間中に最も速いCAGRを記録すると予測されています。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective – 1:
1.10.2 Objective – 2:
1.10.3 Objective – 3:
1.10.4 Objective – 4:
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Pediatric Clinical Trials market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growth in the number of pediatric clinical trials
3.2.1.2 Rising investment in R&D by the pharmaceutical companies
3.2.1.3 High burden of chronic and infectious diseases among the children.
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of clinical studies
3.2.2.2Regulations in New Drug Development
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Pediatric Clinical Trials: Market Analysis Tools
3.6.1 Industry Analysis – Porter’s
3.6.3 PESTEL Analysis
Chapter 4 Pediatric Clinical Trials Market: Phase Analysis
4.1 Pediatric Clinical Trials market: Definition & Scope
4.2 Pediatric clinical trials: Market Share Analysis, 2021 & 2030
4.3 Phase I
4.3.1 Phase I Market, 2018 – 2030 (USD Million)
4.4 Phase II
4.4.1 Phase II market, 2018 – 2030 (USD Million)
4.5 Phase III
4.5.1 Phase III market, 2018 – 2030 (USD Million)
4.6. Phase IV
4.6.1 Phase IV market, 2018 – 2030 (USD Million)
Chapter 5 Pediatric Clinical Trials market: Study Design Analysis
5.1 Pediatric Clinical Trials market: Definition & Scope
5.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
5.3 Treatment Studies
5.3.1 Treatment Studies Market, 2018 – 2030 (USD Million)
5.4. Observational Studies
5.4.1 Observational Studies market, 2018 – 2030 (USD Million)
Chapter 6 Pediatric clinical Trials market: Therapeutic Area Analysis
6.1 Pediatric Clinical Trials market: Definition & Scope
6.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
6.3 Infectious Disease
6.3.1 Infectious Disease Market, 2018 – 2030 (USD Million)
6.4. Oncology
6.4.1 Oncology market, 2018 – 2030 (USD Million)
6.5 Autoimmune/Inflammatory Diseases
6.5.1. Autoimmune / inflammatory diseasesmarket, 2018 – 2030 (USD Million)
6.6 Respiratory Disorders
6.6.1 Respiratory disorders disorders market, 2018 – 2030 (USD Million)
6.7 Mental Health Disorders
6.7.1. Mental health disorders disorders market, 2018 – 2030 (USD Million)
6.8 Others
6.8.1. Others market, 2018 – 2030 (USD Million)
Chapter 7 Pediatric Clinical Trials market: Regional Analysis
7.1 Pediatric Clinical Trials : Market Share Analysis
7.2 North America
7.2.1 North America Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3 Europe
7.3.1 Europe Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3.4 France
7.3.4.1 France Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Pediatric clinical trials market, 2018 – 2030(USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.4.2 India
7.4.2.1 India Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.4.4 China
7.4.4.1 China Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.4.5 Thailand
7.4.5.1 Thailand Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.6 MEA
7.6.1 MEA Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Pediatric clinical trials market, 2018 – 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Pediatric clinical trials market, 2018 – 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 ICON plc
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.2 Syneos Health
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Medpace, Inc.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 PPD Inc.
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Strategic initiatives
8.1.5 Premier Research
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Strategic initiatives
8.1.6 LabCorp Drug Development
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 QPS Holdings.
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.8 Pfizer Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.9 The Emmes Company, LLC
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 IQVIA Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Pediatric Clinical Trials Market, by region, 2018 - 2030 (USD Million)
Table 4 Global Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 5 Global Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 6 Global Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 7 North America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 9 North America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 10 North America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 11 U.S. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 12 U.S. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 13 U.S. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 14 Canada Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 15 Canada Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 16 Canada Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 17 Europe Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 19 Europe Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 20 Europe Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 21 U.K. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 22 U.K. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 23 U.K. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 24 Germany Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 25 Germany Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 26 Germany Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 27 France Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 28 France Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 29 France Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 30 Italy Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 31 Italy Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 32 Italy Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 33 Spain Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 34 Spain Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 35 Spain Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 36 Asia pacific Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia pacific Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 38 Asia pacific Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 39 Asia pacific Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 40 Japan Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 41 Japan Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 42 Japan Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 43 India Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 44 India Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 45 India Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 46 China Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 47 China Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 48 China Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 49 Thailand Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 50 Thailand Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 51 Thailand Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 52 South Korea Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 53 South Korea Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 54 South Korea Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 55 Latin America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 56 Latin America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 57 Latin America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 58 Latin America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 59 Brazil Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 60 Brazil Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 61 Brazil Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 62 Mexico Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 63 Mexico Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 64 Mexico Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 65 Argentina Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 66 Argentina Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 67 Argentina Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 68 Colombia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 69 Colombia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 70 Colombia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 71 MEA Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 72 MEA Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 73 MEA Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 74 MEA Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 75 South Africa Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 76 South Africa Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 77 South Africa Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 78 South Arabia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 79 South Arabia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 80 South Arabia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 81 UAE Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 82 UAE Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 83 UAE Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Pediatric clinical trials market snapshot (2021)
Fig. 6 Pediatric clinical trials market segmentation
Fig. 7 Parent market outlook
Fig. 8 Related/ancillary market outlook
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Pediatric clinical trials market: Phase dashboard
Fig. 15 Pediatric clinical trials market: Phase movement analysis
Fig. 16 Phase I market, 2018 - 2030 (USD Million)
Fig. 17 Phase II market, 2018 - 2030 (USD Million)
Fig. 18 Phase III market, 2018 - 2030 (USD Million)
Fig. 19 Phase IV market, 2018 - 2030 (USD Million)
Fig. 20 Pediatric clinical trials market outlook: study design dashboard
Fig. 21 Pediatric clinical trials market: study design movement analysis
Fig. 22 Treatment studies market, 2018 - 2030 (USD Million)
Fig. 23 Observational studies market, 2018 - 2030 (USD Million)
Fig. 24 Pediatric clinical trials market: Therapeutic Areas movement analysis
Fig. 25 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 26 Oncology market, 2018 - 2030 (USD Million)
Fig. 27 Autoimmune / inflammatory diseases market, 2018 - 2030 (USD Million)
Fig. 28 Respiratory disorders market, 2018 - 2030 (USD Million)
Fig. 29 Mental health disorders market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Global Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 32 North America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 33 U.S. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 34 Canada Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 35 Europe Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 36 U.K. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 37 Germany Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 38 France Trial Site Management organization (SMO) market, 2018 - 2030 (USD Million)
Fig. 39 Italy Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 40 Spain Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 42 Japan Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 43 China Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 44 India Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 45 Thailand Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 46 South Korea Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 47 Latin America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 48 Brazil Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 49 Mexico Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Argentina Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Colombia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 51 Middle East & Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 52 South Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 54 UAE Pediatric Clinical Trials market, 2018 - 2030 (USD Million)

★調査レポート[世界の小児用臨床試験市場2022-2030:フェーズ別(フェーズII、IV)、研究デザイン別(治療、観察研究)、治療領域別(精神疾患、がん)] (コード:GRV22JL082)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の小児用臨床試験市場2022-2030:フェーズ別(フェーズII、IV)、研究デザイン別(治療、観察研究)、治療領域別(精神疾患、がん)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆